To study urine aquaporin-2 level marker for better prognosis after long-term tolvaptan treatment in patients with advanced heart failure.
Phase of Trial: Phase IV
Latest Information Update: 27 Aug 2015
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Biomarker; Therapeutic Use
- 27 Aug 2015 New trial record